title: Letter: prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - authors' reply.
authors.affiliation: Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. arnokornberg@aol.com.
authors.forename: A
authors.initials: A
authors.lastname: Kornberg
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D015427:Reperfusion Injury / Q000150:complications* / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000527:Alprostadil